v3.26.1
Summary of Significant Accounting Policies - Schedule of Assets and Liabilities Measured at Fair Value (Details) - USD ($)
9 Months Ended 12 Months Ended
Dec. 31, 2025
Mar. 31, 2025
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance $ 84,591 $ 288,833
Derivative liabilities recognized at grant date 5,737,755  
Change in fair value of derivative liabilities $ (893,714) (204,242)
Exercise (in Shares) (4,099)  
Ending balance $ 4,924,533 84,591
Recurring [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 84,591  
Ending balance 4,924,533 84,591
Recurring [Member] | Registered Direct Offering Pre-Funded Warrant [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance
Derivative liabilities recognized at grant date 1,013,590  
Change in fair value of derivative liabilities $ (45,250)
Exercise (in Shares)  
Ending balance $ 968,340
Recurring [Member] | August 2020 [Member] | Underwritten Public Offering Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 21 3,219
Change in fair value of derivative liabilities $ (21) (3,198)
Exercise (in Shares)  
Ending balance 21
Recurring [Member] | February 2021 [Member] | Registered Direct Offering Placement Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 219 4,333
Change in fair value of derivative liabilities $ (219) (4,114)
Exercise (in Shares)  
Ending balance 219
Recurring [Member] | May 2021 [Member] | Registered Direct Offering Placement Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 962 6,048
Change in fair value of derivative liabilities $ (962) (5,086)
Exercise (in Shares)  
Ending balance 962
Recurring [Member] | May 2021 [Member] | Registered Direct Offering Investors Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 12,823 80,636
Change in fair value of derivative liabilities $ (12,823) (67,813)
Exercise (in Shares)  
Ending balance 12,823
Recurring [Member] | November 2021 [Member] | Private Placement Offering Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 64,586 179,520
Change in fair value of derivative liabilities $ (60,485) (114,934)
Exercise (in Shares) (4,099)  
Ending balance $ 2 64,586
Recurring [Member] | November 2021 [Member] | Private Placement Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance 5,980 15,077
Change in fair value of derivative liabilities $ (5,979) (9,097)
Exercise (in Shares)  
Ending balance $ 1 5,980
Recurring [Member] | November 2025 [Member] | Private Placement Investors Warrants [Member]    
Schedule of Assets and Liabilities Measured at Fair Value [Line Items]    
Beginning balance
Derivative liabilities recognized at grant date 4,724,165  
Change in fair value of derivative liabilities $ (767,975)
Exercise (in Shares)  
Ending balance $ 3,956,190